Derivation of Clinically Compliant MSCs from CD105+, CD24− Differentiated Human ESCs
Tóm tắt
Adult tissue-derived mesenchymal stem cells (MSCs) have demonstrated therapeutic efficacy in treating diseases or repairing damaged tissues through mechanisms thought to be mediated by either cell replacement or secretion of paracrine factors. Characterized, self-renewing human ESCs could potentially be an invariable source of consistently uniform MSCs for therapeutic applications. Here we describe a clinically relevant and reproducible manner of generating identical batches of hESC-derived MSC (hESC-MSC) cultures that circumvents exposure to virus, mouse cells, or serum. Trypsinization and propagation of HuES9 or H1 hESCs in feeder- and serum-free selection media generated three polyclonal, karyotypically stable, and phenotypically MSC-like cultures that do not express pluripotency-associated markers but displayed MSC-like surface antigens and gene expression profile. They differentiate into adipocytes, osteocytes, and chondrocytes in vitro. Gene expression and fluorescence-activated cell sorter analysis identified CD105 and CD24 as highly expressed antigens on hESC-MSCs and hESCs, respectively. CD105+, CD24− monoclonal isolates have a typical MSC gene expression profiles and were identical to each other with a highly correlated gene expression profile (r2 > .90). We have developed a protocol to reproducibly generate clinically compliant and identical hESC-MSC cultures.
Từ khóa
Tài liệu tham khảo
Le Blanc, 2005, Mesenchymal stem cells: progress toward promise, Cytotherapy, 7, 36, 10.1016/S1465-3249(05)70787-8
Aggarwal, 2005, Human mesenchymal stem cells modulate allogeneic immune cell responses, Blood, 105, 1815, 10.1182/blood-2004-04-1559
Plumas, 2005, Mesenchymal stem cells induce apoptosis of activated T cells, Leukemia, 19, 1597, 10.1038/sj.leu.2403871
Kinnaird, 2004, Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms, Circulation, 109, 1543, 10.1161/01.CIR.0000124062.31102.57
Togel, 2005, Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms, Am J Physiol Renal Physiol, 289, F31, 10.1152/ajprenal.00007.2005
Patschan, 2006, Therapeutic use of stem and endothelial progenitor cells in acute renal injury: ca ira, Curr Opin Pharmacol, 6, 176, 10.1016/j.coph.2005.10.013
Van Overstraeten-Schlogel, 2006, Role of stromal-derived factor-1 in the hematopoietic-supporting activity of human mesenchymal stem cells, Eur J Haematol, 76, 488, 10.1111/j.1600-0609.2006.00633.x
Miyahara, 2006, Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction, Nat Med, 12, 459, 10.1038/nm1391
Gnecchi, 2006, Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement, Faseb J, 20, 661, 10.1096/fj.05-5211com
Gnecchi, 2005, Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells, Nat Med, 11, 367, 10.1038/nm0405-367
Mayer, 2005, Vascular endothelial growth factor (VEGF-A) expression in human mesenchymal stem cells: autocrine and paracrine role on osteoblastic and endothelial differentiation, J Cell Biochem, 95, 827, 10.1002/jcb.20462
Nakagami, 2005, Novel autologous cell therapy in ischemic limb disease through growth factor secretion by cultured adipose tissue-derived stromal cells, Arterioscler Thromb Vasc Biol, 25, 2542, 10.1161/01.ATV.0000190701.92007.6d
Cheng, 2000, Human mesenchymal stem cells support megakaryocyte and pro-platelet formation from CD34(+) hematopoietic progenitor cells, J Cell Physiol, 184, 58, 10.1002/(SICI)1097-4652(200007)184:1<58::AID-JCP6>3.0.CO;2-B
Xu, 2004, Immortalized fibroblast-like cells derived from human embryonic stem cells support undifferentiated cell growth, Stem Cells, 22, 972, 10.1634/stemcells.22-6-972
Barberi, 2005, Derivation of multipotent mesenchymal precursors from human embryonic stem cells, PLoS Med, 2, e161, 10.1371/journal.pmed.0020161
van den Bos, 1997, Human mesenchymal stem cells respond to fibroblast growth factors, Hum Cell, 10, 45
Kilian, 2004, Effects of platelet growth factors on human mesenchymal stem cells and human endothelial cells in vitro, Eur J Med Res, 9, 337
Cowan, 2004, Derivation of embryonic stem-cell lines from human blastocysts, N Engl J Med, 350, 1353, 10.1056/NEJMsr040330
Thomson, 1998, Embryonic stem cell lines derived from human blastocysts, Science, 282, 1145, 10.1126/science.282.5391.1145
Pittenger, 1999, Multilineage potential of adult human mesenchymal stem cells, Science, 284, 143, 10.1126/science.284.5411.143
Damjanov, 1987, Teratocarcinomas and embryonic stem cells: a practical approach, 1
Yin, 2002, AFP(+), ESC-Derived cells engraft and differentiate into hepatocytes in vivo, Stem Cells, 20, 338, 10.1634/stemcells.20-4-338
Que, 2004, Generation of hybrid cell lines with endothelial potential from spontaneous fusion of adult bone marrow cells with embryonic fibroblast feeder, In Vitro Cell Dev Biol Anim, 40, 143, 10.1290/1543-706X(2004)40<143:GOHCLW>2.0.CO;2
Javazon, 2004, Mesenchymal stem cells: paradoxes of passaging, Exp Hematol, 32, 414, 10.1016/j.exphem.2004.02.004
Barry, 2004, Mesenchymal stem cells: clinical applications and biological characterization, Int J Biochem Cell Biol, 36, 568, 10.1016/j.biocel.2003.11.001
Majumdar, 2003, Characterization and functionality of cell surface molecules on human mesenchymal stem cells, J Biomed Sci, 10, 228, 10.1007/BF02256058
Rosen, 2005, The transcriptional basis of adipocyte development, Prostaglandins Leukot Essent Fatty Acids, 73, 31, 10.1016/j.plefa.2005.04.004
Okazaki, 2004, Extracellular matrix gene regulation, Clin Orthop Relat Res, S123, 10.1097/01.blo.0000144478.51284.f3
Barreau, 2005, AU-rich elements and associated factors: are there unifying principles?, Nucleic Acids Res, 33, 7138, 10.1093/nar/gki1012
Espel, 2005, The role of the AU-rich elements of mRNAs in controlling translation, Semin Cell Dev Biol, 16, 59, 10.1016/j.semcdb.2004.11.008
Gerstenfeld, 1996, Expression of bone-specific genes by hypertrophic chondrocytes: implication of the complex functions of the hypertrophic chondrocyte during endochondral bone development, J Cell Biochem, 62, 1, 10.1002/(SICI)1097-4644(199607)62:1<1::AID-JCB1>3.0.CO;2-X
Knott, 1998, Collagen cross-links in mineralizing tissues: a review of their chemistry, function, and clinical relevance, Bone, 22, 181, 10.1016/S8756-3282(97)00279-2
Gotherstrom, 2005, Difference in gene expression between human fetal liver and adult bone marrow mesenchymal stem cells, Haematologica, 90, 1017
Su, 1996, Mitogen-activated protein kinase cascades and regulation of gene expression, Curr Opin Immunol, 8, 402, 10.1016/S0952-7915(96)80131-2
Torres, 2003, Redox signaling and the MAP kinase pathways, Biofactors, 17, 287, 10.1002/biof.5520170128
Matsukawa, 2004, The ASK1-MAP kinase cascades in mammalian stress response, J Biochem (Tokyo), 136, 261, 10.1093/jb/mvh134
Sekine, 2006, The ASK1-MAP kinase signaling in ER stress and neurodegenerative diseases, Curr Mol Med, 6, 87, 10.2174/156652406775574541
Cai, 2005, Assessing self-renewal and differentiation in hESC lines, Stem Cells, 24, 516, 10.1634/stemcells.2005-0143
Le Blanc, 2003, Immunomodulatory effects of fetal and adult mesenchymal stem cells, Cytotherapy, 5, 485, 10.1080/14653240310003611
Reubinoff, 2000, Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro, Nat Biotechnol, 18, 399, 10.1038/74447
Thalmeier, 2001, Mesenchymal differentiation and organ distribution of established human stromal cell lines in NOD/SCID mice, Acta Haematol, 105, 159, 10.1159/000046559
Xia, 2004, Macrophagic response to human mesenchymal stem cell and poly(epsilon-caprolactone) implantation in nonobese diabetic/severe combined immunodeficient mice, J Biomed Mater Res A, 71, 538, 10.1002/jbm.a.30185